Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-066384

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 13, 2015
Accepted (ET)
Aug 17, 2015 · 6:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 13, 2015S43,755$16.75D450,222ISee Footnote
Common StockF1,F3Aug 13, 2015S2,352$16.75D24,206ISee Footnote
Common StockF1,F4Aug 13, 2015S45,112$16.75D464,177ISee Footnote
Common StockF1,F5Aug 13, 2015S996$16.75D10,249ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Following the transaction reported in this Form 4, Wilfred Jaeger, as a director of the Issuer, will remain subject to Section 16.